Profil
Bruce N.
Rogers is currently the President at Morphic Therapeutic, Inc. He previously worked as the Head-Neuro Opportunities at Pfizer Inc. from 2014 to 2016 and as a Scientist at Pharmacia & Upjohn Co. LLC from 1998 to 2003.
Additionally, he served as the President at Morphic Holding, Inc. in 2024.
Dr. Rogers holds a doctorate degree from the University of California, Irvine and an undergraduate degree from the University of Minnesota.
Aktiva positioner av Bruce Rogers
| Företag | Position | Start |
|---|---|---|
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Researches and develops small molecules to block transmembrane integrin receptors | President | 2022-05-01 |
Tidigare kända positioner av Bruce Rogers
| Företag | Position | Slut |
|---|---|---|
| MORC HOLD | Verkställande Direktör | 2024-01-02 |
| PFIZER INC. | Företagsledare/Principal | 2016-01-01 |
Pharmacia & Upjohn Co. LLC
Pharmacia & Upjohn Co. LLC Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical goods | Företagsledare/Principal | 2003-08-01 |
Bruce Rogerss utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
University of California, Irvine
University of California, Irvine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Minnesota
University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmacia & Upjohn Co. LLC
Pharmacia & Upjohn Co. LLC Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical goods | Health Technology |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Researches and develops small molecules to block transmembrane integrin receptors | Health Technology |
Morphic Holding, Inc.
Morphic Holding, Inc. Pharmaceuticals: MajorHealth Technology Develops oral integrin drugs | Health Technology |
















